{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:07:46Z","timestamp":1789736866769,"version":"4.0.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5472","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T22:12:13Z","timestamp":1477951933000},"page":"3181-3184","source":"Crossref","is-referenced-by-count":13,"title":["Two Cases of Acute Disseminated Encephalomyelitis Following Vaccination Against Human Papilloma Virus"],"prefix":"10.2169","volume":"55","author":[{"given":"Kenji","family":"Sekiguchi","sequence":"first","affiliation":[{"name":"Division of Neurology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Yasui","sequence":"additional","affiliation":[{"name":"Division of Neurology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomo","family":"Kowa","sequence":"additional","affiliation":[{"name":"Division of Neurology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Kanda","sequence":"additional","affiliation":[{"name":"Division of Neurology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[{"name":"Division of Neurology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 84: 118-131, 2009."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Langer-Gould A, Qian L, Tartof SY, et al. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol 71: 1506-1513, 2014.","DOI":"10.1001\/jamaneurol.2014.2633"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev 13: 215-224, 2014.","DOI":"10.1016\/j.autrev.2013.10.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wade BJ. Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale. Mult Scler Int 2014: 124578, 2014.","DOI":"10.1155\/2014\/124578"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 13: 89-99, 2012.","DOI":"10.1016\/S1470-2045(11)70286-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Menge T, Cree B, Saleh A, et al. Neuromyelitis optica following human papillomavirus vaccination. Neurology 79: 285-287, 2012.","DOI":"10.1212\/WNL.0b013e31825fdead"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Angelo MG, David MP, Zima J, et al. Pooled analysis of large and long-term safety data from the human papillomavirus-16\/18-AS04-adjuvanted vaccine clinical trial programme. Pharmacoepidemiol Drug Saf 23: 466-479, 2014.","DOI":"10.1002\/pds.3554"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Grimaldi-Bensouda L, Guillemot D, Godeau B, et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med 275: 398-408, 2014.","DOI":"10.1111\/joim.12155"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68: S7-S12, 2007.","DOI":"10.1212\/01.wnl.0000259422.44235.a8"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56: 1313-1318, 2001.","DOI":"10.1212\/WNL.56.10.1313"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: Literature review and illustrative case. J Clin Neurosci 15: 1315-1322, 2008.","DOI":"10.1016\/j.jocn.2008.05.002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126: 770-824, 2003.","DOI":"10.1093\/brain\/awg081"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14: 1157-1174, 2008.","DOI":"10.1177\/1352458508096878"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Yonee C, Toyoshima M, Maegaki Y, et al. Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report. Neuropediatrics 44: 265-267, 2013.","DOI":"10.1055\/s-0033-1333873"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Menge T, Kieseier BC, Nessler S, Hemmer B, Hartung HP, Stuve O. Acute disseminated encephalomyelitis: an acute hit against the brain. Curr Opin Neurol 20: 247-254, 2007.","DOI":"10.1097\/WCO.0b013e3280f31b45"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Wildemann B, Jarius S, Hartmann M, Regula JU, Hametner C. Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology 72: 2132-2133, 2009.","DOI":"10.1212\/WNL.0b013e3181aa53bb"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sutton I, Lahoria R, Tan I, Clouston P, Barnett M. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 15: 116-119, 2009.","DOI":"10.1177\/1352458508096868"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. DiMario FJ, Hajjar M, Ciesielski T. A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus. J Child Neurol 25: 321-327, 2010.","DOI":"10.1177\/0883073809349322"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chang J, Campagnolo D, Vollmer TL, Bomprezzi R. Demyelinating disease and polyvalent human papilloma virus vaccination. J Neurol Neurosurg Psychiatry 82: 1296-1298, 2011.","DOI":"10.1136\/jnnp.2010.214924"},{"key":"20","unstructured":"20. Pharmaceuticals and Medical Devices Agency. PMDA Risk Communications: Drug Risk Information of Ongoing Evaluation [Internet]. [cited 2015 Mar. 30]. Available from: http:\/\/www.info.pmda.go.jp\/fsearchnew\/jsp\/menu_fukusayou_base.jsp"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.5472\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:28:46Z","timestamp":1498357726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.5472\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":20,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5472","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}